These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 16434309)
1. From mesothelioma to cardiovascular protection via the phosphoinositide-3 kinase pathway: a new vista in cardiothoracic surgery. Konstantinov IE; Li J; Redington AN J Thorac Cardiovasc Surg; 2006 Feb; 131(2):509-10; author reply 510. PubMed ID: 16434309 [No Abstract] [Full Text] [Related]
2. Receptor tyrosine kinase and phosphoinositide-3 kinase signaling in malignant mesothelioma. Rascoe PA; Cao X; Daniel JC; Miller SD; Smythe WR J Thorac Cardiovasc Surg; 2005 Aug; 130(2):393-400. PubMed ID: 16077404 [TBL] [Abstract][Full Text] [Related]
3. Reperfusion injury revisited: is there a role for growth factor signaling in limiting lethal reperfusion injury? Yellon DM; Baxter GF Trends Cardiovasc Med; 1999 Nov; 9(8):245-9. PubMed ID: 11094333 [TBL] [Abstract][Full Text] [Related]
4. No risk, no ... cardioprotection? A critical perspective. Heusch G Cardiovasc Res; 2009 Nov; 84(2):173-5. PubMed ID: 19713282 [No Abstract] [Full Text] [Related]
5. Remote preconditioning provides potent cardioprotection via PI3K/Akt activation and is associated with nuclear accumulation of β-catenin. Li J; Xuan W; Yan R; Tropak MB; Jean-St-Michel E; Liang W; Gladstone R; Backx PH; Kharbanda RK; Redington AN Clin Sci (Lond); 2011 May; 120(10):451-62. PubMed ID: 21143191 [TBL] [Abstract][Full Text] [Related]
6. Hypotonicity stimulates renal epithelial sodium transport by activating JNK via receptor tyrosine kinases. Taruno A; Niisato N; Marunaka Y Am J Physiol Renal Physiol; 2007 Jul; 293(1):F128-38. PubMed ID: 17344192 [TBL] [Abstract][Full Text] [Related]
7. Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma. Jagadeeswaran R; Ma PC; Seiwert TY; Jagadeeswaran S; Zumba O; Nallasura V; Ahmed S; Filiberti R; Paganuzzi M; Puntoni R; Kratzke RA; Gordon GJ; Sugarbaker DJ; Bueno R; Janamanchi V; Bindokas VP; Kindler HL; Salgia R Cancer Res; 2006 Jan; 66(1):352-61. PubMed ID: 16397249 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy. Fischer B; Frei C; Moura U; Stahel R; Felley-Bosco E Lung Cancer; 2012 Oct; 78(1):23-9. PubMed ID: 22857894 [TBL] [Abstract][Full Text] [Related]
9. Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Lacerda L; Somers S; Opie LH; Lecour S Cardiovasc Res; 2009 Nov; 84(2):201-8. PubMed ID: 19666677 [TBL] [Abstract][Full Text] [Related]
10. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. Badache A; Hynes NE Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of autophagy via activation of PI3K/Akt/mTOR pathway contributes to the protection of hesperidin against myocardial ischemia/reperfusion injury. Li X; Hu X; Wang J; Xu W; Yi C; Ma R; Jiang H Int J Mol Med; 2018 Oct; 42(4):1917-1924. PubMed ID: 30066841 [TBL] [Abstract][Full Text] [Related]
12. Urinary trypsin inhibition: cardioprotection via the reperfusion injury salvage kinase pathway. Hausenloy DJ Cardiology; 2009; 114(4):261-3. PubMed ID: 19684395 [No Abstract] [Full Text] [Related]
13. Role of phosphoinositide 3-kinase IA (PI3K-IA) activation in cardioprotection induced by ouabain preconditioning. Duan Q; Madan ND; Wu J; Kalisz J; Doshi KY; Haldar SM; Liu L; Pierre SV J Mol Cell Cardiol; 2015 Mar; 80():114-25. PubMed ID: 25575882 [TBL] [Abstract][Full Text] [Related]
14. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors. Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409 [TBL] [Abstract][Full Text] [Related]
15. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways. Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030 [TBL] [Abstract][Full Text] [Related]
16. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. Pagel PS; Krolikowski JG; Shim YH; Venkatapuram S; Kersten JR; Weihrauch D; Warltier DC; Pratt PF Anesth Analg; 2007 Sep; 105(3):562-9. PubMed ID: 17717207 [TBL] [Abstract][Full Text] [Related]
17. (‑)‑Epicatechin protects against myocardial ischemia‑induced cardiac injury via activation of the PTEN/PI3K/AKT pathway. Li JW; Wang XY; Zhang X; Gao L; Wang LF; Yin XH Mol Med Rep; 2018 Jun; 17(6):8300-8308. PubMed ID: 29658565 [TBL] [Abstract][Full Text] [Related]
18. Collagen I induction by high glucose levels is mediated by epidermal growth factor receptor and phosphoinositide 3-kinase/Akt signalling in mesangial cells. Wu D; Peng F; Zhang B; Ingram AJ; Gao B; Krepinsky JC Diabetologia; 2007 Sep; 50(9):2008-2018. PubMed ID: 17622510 [TBL] [Abstract][Full Text] [Related]